Newport News, VA, January 3, 2023– ivWatch, LLC, the inventor and manufacturer of the only continuous IV site monitoring technology, announced today their presence at the Society for Critical Care Medicine’s annual Critical Care Congress for the first time. To support the company’s growth trajectory, 2023 will be the largest in-person event schedule to date. The groundbreaking infiltration detection innovation will be on prominent display for the highly trained critical care clinicians.
ivWatch will be exhibiting in Booth 1141 in San Francisco, California on January 21-24. There will be in-person demonstrations of the ivWatch technology for the early detection of infiltrations and extravasations for the duration of the event.
Stay tuned for more events on the company’s website as this year’s event cadence will give clinicians globally, an opportunity to connect with ivWatch’s clinical specialists and product experts.
About ivWatch, LLC
ivWatch, LLC is a biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians can leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative IV site monitoring solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch, Facebook @ivWatchLLC, and LinkedIn @ivWatch-LLC, or visit www.ivWatch.com.
MEDIA CONTACT:
Erin Wendell
erin.wendell@ivwatch.com
Mobile (410) 952-3800